Sat, Aug 23, 2014, 10:56 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • rehdvm2004 rehdvm2004 Mar 22, 2014 12:08 PM Flag

    Even Longs forget . . .

    that Inovio has a $3.5 million contract with DOD to comparatively evaluate the efficacy of currently used vaccination techniques (pneumatic syringe) with electorporesis. If positive results are achieved there, the entire procedure for preventive immunizations for armed forces personnel, Peace Corps volunteers, CDC field agents, etc., etc. will change dramatically. I know that these studies and the data are confidential between Inovio and DOD, but that one could be a major bell ringer. I think that DOD solicited the trial like FDA solicited INSM to do the NTM trial with Arikace. We shall see.

    GLTAL

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I was not familiar with this one as I bought my original shares in August, after it's first spike above $3.00 on a recommendation from a serious biotech friend. He mentioned it in June when it was $0.62 DUH!!!

      What are the milestone payments beyond the $3.5 million if I might ask?

      Now that INO is optionable, I'm getting serious about the company, (I like what I am seeing so far.) On March 10th I sold a rather large pile of April $2.50 puts and have bought some August calls at all three strikes plus added to my early long position. All good so far...

      Sentiment: Strong Buy

    • heretostayiloveinovio heretostayiloveinovio Mar 22, 2014 12:40 PM Flag

      I never forgot rehdvm! And like you wrote, "I know that these studies and the data are confidential between Inovio and DOD" which makes sense! All is falling into place nicely!

      Sentiment: Strong Buy

 
INO
10.71+0.13(+1.23%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.